Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What is the evidence for lymphadenectomy in presumed early ovarian cancer?
Schmalfeldt B, Brambs C, Burges A, El-Balat A, Emons G, Fink D, Fotopoulou C, Gropp-Meier M, Hanker LC, Harter P, Hasenburg A, Hauptmann S, Hilpert F, Kimmig R, Kommoss S, Kurzeder C, Mahner S, Marmé F, Mayr D, Meier W, Meinhold-Heerlein I, Mustea A, Ortmann O, Oskay-Özcelik G, Pfisterer J, Pölcher M, Runnebaum IB, Schröder W, Tanner B, Wagner U, Wimberger P, Sehouli J. Schmalfeldt B, et al. Among authors: burges a. Arch Gynecol Obstet. 2019 Jan;299(1):1-5. doi: 10.1007/s00404-018-4945-8. Arch Gynecol Obstet. 2019. PMID: 30374648 No abstract available.
Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients.
Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Czogalla B, et al. Among authors: burges a. Int J Mol Sci. 2018 Dec 29;20(1):112. doi: 10.3390/ijms20010112. Int J Mol Sci. 2018. PMID: 30597961 Free PMC article.
Extracapsular Lymph Node Involvement in Ovarian Carcinoma.
Heublein S, Schulz H, Marmé F, Angele M, Czogalla B, Burges A, Mahner S, Mayr D, Jeschke U, Schmoeckel E. Heublein S, et al. Among authors: burges a. Cancers (Basel). 2019 Jul 1;11(7):924. doi: 10.3390/cancers11070924. Cancers (Basel). 2019. PMID: 31266250 Free PMC article.
Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer.
Dötzer K, Schlüter F, Schoenberg MB, Bazhin AV, von Koch FE, Schnelzer A, Anthuber S, Grab D, Czogalla B, Burges A, Werner J, Mahner S, Mayer B. Dötzer K, et al. Among authors: burges a. Cancers (Basel). 2019 Aug 26;11(9):1250. doi: 10.3390/cancers11091250. Cancers (Basel). 2019. PMID: 31455033 Free PMC article.
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.
Czogalla B, Kuhn C, Heublein S, Schmöckel E, Mayr D, Kolben T, Trillsch F, Burges A, Mahner S, Jeschke U, Hester A. Czogalla B, et al. Among authors: burges a. J Cancer Res Clin Oncol. 2019 Oct;145(10):2519-2527. doi: 10.1007/s00432-019-03017-8. Epub 2019 Sep 4. J Cancer Res Clin Oncol. 2019. PMID: 31485769
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology.
Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Hester A, Zeder-Göß C, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Czogalla B, et al. Among authors: burges a. Cancer Manag Res. 2019 Aug 14;11:7673-7684. doi: 10.2147/CMAR.S210004. eCollection 2019. Cancer Manag Res. 2019. PMID: 31616183 Free PMC article.
179 results